Retatrutide: Phase 2 and TRIUMPH results Retatrutide clinical data comes from two major sources: the Phase 2 obesity trial published in the New England Journal of Medicine, and the recently announced Phase 3 TRIUMPH-4 results
To understand why shedding happens, it helps to look at the hair growth cycle
Niacinamide has anti-inflammatory properties and supports NAD+ biosynthesis, which is relevant for metabolic function and cellular repair
Flawless MedSpa encourages patients to keep up with healthy lifestyle habits, such as exercise and diet, for the best possible results when taking Semaglutide GLP-1 shots
To preserve their adipogenic potential, they need to avoid long-term expansion on stiff substrates and be exposed to lipid-inducing media in combination with scaffold cues
Retatrutide's Phase 3 safety data (TRIUMPH-4) has been described as qualitatively similar to tirzepatide and semaglutide, though some trial reporting notes a somewhat higher rate of GI adverse events with retatrutide's added glucagon receptor activity
